Advanced Cell Therapies

The FRC Blood Service develops and manufactures new advanced cell therapy products (ATMP) and provides tissue engineering services for Finnish health care providers. The Blood Service carries out active research and development in the field of novel advanced cell therapy products together with Finnish medical research groups and international partners.